|
Market Closed -
OTC Markets
22:30:00 05/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.2370 USD | -46.49% |
|
-64.32% | -90.88% |
| 11-04 | 15 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 11-03 | 17 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| Market Cap | 48.54M 4.96M 4.42M 4.04M 3.68M 6.94M 468M 7.12M 19.41M 248M 18.61M 18.21M 783M | P/E 2024 |
-2.97x | P/E 2025 | 1.63x |
|---|---|---|---|---|---|
| Enterprise Value | -372M -38.03M -33.89M -30.99M -28.23M -53.21M -3.59B -54.64M -149M -1.9B -143M -140M -6.01B | EV / Sales 2024 |
1.62x | EV / Sales 2025 | 23.8x |
| Free-Float |
78.37% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Orexo AB
| 1 day | -46.49% | ||
| 1 week | -64.32% | ||
| Current month | -64.32% | ||
| 1 month | -78.45% | ||
| 3 months | -86.61% | ||
| 6 months | -88.41% | ||
| Current year | -90.88% |
| 1 week | 0.24 |  | 0.44 |
| 1 month | 0.24 | | 0.75 |
| Current year | 0.24 | | 2.65 |
| 1 year | 0.24 | | 3 |
| 3 years | 0.24 | | 4.05 |
| 5 years | 0.24 | | 4.05 |
| 10 years | 0.24 | | 9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nikolaj Sørensen
CEO | Chief Executive Officer | 54 | 05/02/2013 |
Fredrik Järrsten
DFI | Director of Finance/CFO | 59 | 01/09/2022 |
Jonas Savmarker
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 01/01/2002 | |
George Wilkinson
BRD | Director/Board Member | 70 | 11/04/2019 |
Christine Rankin
BRD | Director/Board Member | 62 | 01/04/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -46.49% | -64.32% | - | - | 4.96M | |
| -3.76% | -0.65% | +47.41% | +140.35% | 1,216B | |
| -1.45% | -1.05% | +46.41% | +79.94% | 656B | |
| -2.24% | -0.88% | +32.97% | +103.82% | 509B | |
| -2.13% | -4.73% | +44.91% | +62.05% | 384B | |
| -2.27% | +0.42% | +74.12% | +42.14% | 362B | |
| -2.31% | -1.88% | +28.79% | +55.82% | 311B | |
| -2.91% | -2.20% | +6.38% | +32.87% | 293B | |
| -3.80% | -0.10% | +43.90% | +70.56% | 249B | |
| -3.96% | +1.18% | +36.70% | +105.38% | 208B | |
| Average | -7.14% | +0.60% | +40.18% | +76.99% | 465.31B | |
| Weighted average by Cap. | -2.79% | +0.03% | +42.58% | +91.09% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 590M 60.25M 53.69M 49.11M 44.73M 84.31M 5.69B 86.58M 236M 3.02B 226M 221M 9.52B | 26M 2.66M 2.37M 2.16M 1.97M 3.72M 251M 3.82M 10.4M 133M 9.97M 9.75M 419M |
| Net income | -203M -20.73M -18.47M -16.9M -15.39M -29.01M -1.96B -29.79M -81.17M -1.04B -77.82M -76.14M -3.27B | 639M 65.29M 58.18M 53.21M 48.46M 91.35M 6.17B 93.81M 256M 3.27B 245M 240M 10.31B |
| Net Debt | 353M 36.02M 32.1M 29.36M 26.74M 50.4M 3.4B 51.76M 141M 1.8B 135M 132M 5.69B | -421M -42.98M -38.3M -35.04M -31.91M -60.14M -4.06B -61.76M -168M -2.15B -161M -158M -6.79B |
Employees
55
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/11/26 | US$0.2370 | -46.49% | 400 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ORX Stock
- ORXOY Stock
Select your edition
All financial news and data tailored to specific country editions
